Autologous Stem Cell Harvesting for Waldenstrom's Macroglobulinemia
OBJECTIVES:
- Harvest and store adequate CD34+ stem cells from patients with Waldenstrom's
macroglobulinemia (WM) for potential future use in transplantation strategies.
- Evaluate the ability to harvest stem cells after therapy for WM (e.g.,
fludarabine-based chemotherapy) by evaluating the number of days to adequate harvest.
- Collect aliquots of stem cells for future research analysis as part of a WM database
project.
OUTLINE: Patients undergo collection of autologous stem cells beginning on day 4 or 5 and
continuing until an adequate number of stem cells are collected. Cells are then
cryopreserved.
PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study.
Observational
N/A
Number of days to adequate stem cell harvest
No
Gwen L. Nichols, MD
Study Chair
Herbert Irving Comprehensive Cancer Center
Unspecified
CDR0000487602
NCT00899119
November 2005
Name | Location |
---|---|
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center | New York, New York 10032 |